ResMed | RMD - Stammkapital

Aktienkurs
32.13
Täglich Wechseln
-0.15 -0.46%
Monatlich
-11.34%
Jährlich
-8.51%
Q1 Prognose
31.44




Stammkapital Veränderung Datum
Ansell USD 142.94M 885.26M 2025-12
Cochlear AUD 65.4M 1.12B 2025-12
CSL USD 482.13M 93.87M 2025-12
Fisher & Paykel Healthcare NZD 587.25M 1.35M 2025-12
Healius AUD 2.6B 100K 2024-12
Integral Diagnostics AUD 335.09M 1.07M 2024-06
Mayne Pharma AUD 81.25M 0 2025-06
Nanosonics AUD 303.35M 188.61M 2025-12
Polynovo AUD 690.84M 991 2025-12
Ramsay Health Care AUD 229.93M 29.81K 2025-12
Regis Healthcare AUD 302.36M 1.11M 2025-12
ResMed USD 145.66M 279.42K 2025-12
Sigma Healthcare AUD 11.5B 9.93B 2025-12
Sonic Healthcare AUD 4.15B 467K 2024-12
Telix Pharmaceuticals AUD 338.78M 379K 2025-12